ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

NIH Slow To Implement Equality In Studies, GAO Says, But Waxman Assures Reauthorization

June 22, 1990

Ann Landers, Columnist Who Urged Support for Cancer Act, Dead

June 28, 2002

Nancy Brinker Resigns As CEO of Komen

August 10, 2012

In Brief: Gift to Jefferson Funds Capizzi Professorship; Abrams Named Special Assistant to DDES

January 9, 1998

MSKCC Asked To Repay $638,371 To NIH

December 13, 1985

Cell Behavior Changes Noted At Baltimore Symposium

January 8, 1982